Anavex Life Sciences Corp.
Biotechnology company · New York, United States · Nasdaq: AVXL
Anavex Life Sciences Corp. is a biotechnology company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker AVXL. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2014.
Anavex Life Sciences at a glance
What does Anavex Life Sciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $10 million sold (2014).
Frequently asked questions about Anavex Life Sciences
Where is Anavex Life Sciences headquartered?
Anavex Life Sciences Corp. is headquartered in New York, United States.
What does Anavex Life Sciences do?
Anavex Life Sciences Corp. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Anavex Life Sciences a public company?
Yes. Anavex Life Sciences Corp. trades on Nasdaq under the ticker AVXL.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.